Providers Embrace US FDA REMS Integration Plan But Wary Of Another iPledge ‘Failure’

Providers are eager for the FDA to test integrating REMS requirements into electronic health records, but want the agency to ‘go slowly’ to avoid any disruptions along the way. Recent issues with two of the original restricted distribution plans in the US underscore the message of caution.

risk mitigation
Patients and providers stressed that back-up plans be in place when the new REMS integration software is tested. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet